The effect of vitamin D on all-cause mortality in congestive heart failure patients - EVITA
Phase 1
- Conditions
- Substitution of low vitamin D levels in congestive heart failure patients
- Registration Number
- EUCTR2010-020793-42-DE
- Lead Sponsor
- Clinic for Thoracic and Cardiovascular Surgery, Heart Centre North Rhine-Westfalia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Patients with congestive heart failure NYHA class not less than II
- Men and women in the age of > 18 and > 80 years old
- Signed consent form
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- High urgent listing for cardiac transplantation
- History of sarcoidosis, nephrolithiasis
- Pregnancy, Lactation
- Concomitant medication of vitamin D > 25µg/d
- Vitamin D blood levels >75 nmol/L
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method